Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122008083 | 12200808 | 3 | F | 20160628 | 20160322 | 20160811 | PER | PHEH2016US006657 | NOVARTIS | 0.00 | F | Y | 96.36000 | KG | 20160811 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122008083 | 12200808 | 1 | PS | ENTRESTO | SACUBITRILVALSARTAN | 1 | Oral | 50 MG (24/26MG ), UNK | 207620 | 50 | MG | ||||||||
| 122008083 | 12200808 | 2 | SS | ENTRESTO | SACUBITRILVALSARTAN | 1 | Oral | 200 MG (97/103 MG), BID | F0002 | 207620 | 200 | MG | BID | ||||||
| 122008083 | 12200808 | 3 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 122008083 | 12200808 | 4 | C | PRILOSEC//OMEPRAZOLE | 2 | Unknown | U | 0 | |||||||||||
| 122008083 | 12200808 | 5 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Oral | 18 UG, UNK | U | 0 | 18 | UG | |||||||
| 122008083 | 12200808 | 6 | C | TORSEMIDE. | TORSEMIDE | 1 | Unknown | U | 0 | ||||||||||
| 122008083 | 12200808 | 7 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 25 MG, BID | 0 | 25 | MG | BID | |||||||
| 122008083 | 12200808 | 8 | C | ASPIRIN /00346701/ | ASCORBIC ACIDASPIRIN | 1 | Oral | 81 MG, QD | 0 | 81 | MG | QD | |||||||
| 122008083 | 12200808 | 9 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 12.5 UG, QD | 0 | 12.5 | UG | QD | |||||||
| 122008083 | 12200808 | 10 | C | WARFARIN | WARFARIN | 1 | Unknown | 5 MG, UNK | U | 0 | 5 | MG | |||||||
| 122008083 | 12200808 | 11 | C | PREVACID | LANSOPRAZOLE | 1 | Oral | U | 0 | ||||||||||
| 122008083 | 12200808 | 12 | C | CLARITIN | LORATADINE | 1 | Oral | U | 0 | ||||||||||
| 122008083 | 12200808 | 13 | SS | PROAIR HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | UNK UNK, PRN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122008083 | 12200808 | 1 | Product used for unknown indication |
| 122008083 | 12200808 | 3 | Product used for unknown indication |
| 122008083 | 12200808 | 4 | Product used for unknown indication |
| 122008083 | 12200808 | 5 | Product used for unknown indication |
| 122008083 | 12200808 | 6 | Product used for unknown indication |
| 122008083 | 12200808 | 7 | Product used for unknown indication |
| 122008083 | 12200808 | 8 | Product used for unknown indication |
| 122008083 | 12200808 | 9 | Product used for unknown indication |
| 122008083 | 12200808 | 10 | Product used for unknown indication |
| 122008083 | 12200808 | 11 | Product used for unknown indication |
| 122008083 | 12200808 | 12 | Product used for unknown indication |
| 122008083 | 12200808 | 13 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122008083 | 12200808 | Alopecia | |
| 122008083 | 12200808 | Asthma | |
| 122008083 | 12200808 | Dyspnoea | |
| 122008083 | 12200808 | Malaise | |
| 122008083 | 12200808 | Sinusitis | |
| 122008083 | 12200808 | Urinary tract infection | |
| 122008083 | 12200808 | Vitamin B12 decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |